NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells: Research paper

British Journal of Haematology

Volumn 148, Issue 6, 2010, Pages 868-878

  Hubmann, Rainer ^a,b   Düchler, Markus ^a   Schnabl, Susanne ^a   Hilgarth, Martin ^a   Demirtas, Dita ^a   Mitteregger, Dieter ^a   Hölbl, Andrea ^a   Vanura, Katrina ^a   Le, Trang ^a   Look, Thomas ^c   Schwarzmeier, Josef D ^a   Valent, Peter ^a,b   Jäger, Ulrich ^a   Shehata, Medhat ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Cluster Oncology ^*  (Austria)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

CD23; Chronic lymphocytic leukaemia; IFN ; NOTCH2; PKC

Indexed keywords

CD23 ANTIGEN; GAMMA INTERFERON; GAMMA SECRETASE INHIBITOR; NOTCH2 RECEPTOR; PROTEIN KINASE C; PROTEIN KINASE C DELTA; IMMUNOGLOBULIN E RECEPTOR; NOTCH2 PROTEIN, HUMAN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; ANTAGONISTS AND INHIBITORS; GENETICS; IMMUNOLOGY; METABOLISM; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ANTIGENS, NEOPLASM; HUMANS; INTERFERON-GAMMA; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NEOPLASM PROTEINS; PROGNOSIS; PROTEIN KINASE C-DELTA; RECEPTOR, NOTCH2; RECEPTORS, IGE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77649207387     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08024.x     Document Type: Article

References (48)

1. Androutsellis-Theotokis, A., Leker, R.R., Soldner, F., Hoeppner, D.J., Ravin, R., Poser, S.W., Rueger, M.A., Bae, S.K., Kittappa, R. McKay, R.D. (2006) Notch signalling regulates stem cell numbers in vitro and in vivo. Nature, 442, 823 826.
2. Artavanis-Tsakonas, S., Rand, M.D. Lake, R.J. (1999) Notch signaling: cell fate control and signal integration in development. Science, 284, 770 776.
3. Barragan, M., Bellosillo, B., Campas, C., Colomer, D., Pons, G. Gil, J. (2002) Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood, 99, 2969 2976.
4. Baudot, A.D., Jeandel, P.Y., Mouska, X., Maurer, U., Tartare-Deckert, S., Raynaud, S.D., Cassuto, J.P., Ticchioni, M. Deckert, M. (2009) The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Oncogene, 28, 3261 3273.
5. Bertrand, F.E., Eckfeldt, C.E., Fink, J.R., Lysholm, A.S., Pribyl, J.A., Shah, N. LeBien, T.W. (2000) Microenvironmental influences on human B-cell development. Immunological Reviews, 175, 175 186.
6. Bigas, A., Martin, D.I. Milner, L.A. (1998) Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Molecular and Cellular Biology, 18, 2324 2333.
7. Buschle, M., Campana, D., Carding, S.R., Richard, C., Hoffbrand, A.V. Brenner, M.K. (1993) Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. Journal of Experimental Medicine, 177, 213 218.
8. Caligaris-Cappio, F. (1996) B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood, 87, 2615 2620.
9. Capobianco, A.J., Zagouras, P., Blaumueller, C.M., Artavanis-Tsakonas, S. Bishop, J.M. (1997) Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Molecular and Cellular Biology, 17, 6265 6273.
10. Chiorazzi, N. Ferrarini, M. (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annual Review of Immunology, 21, 841 894.
11. Cordier-Bussat, M., Billaud, M., Calender, A. Lenoir, G.M. (1993) Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context. International Journal of Cancer, 53, 153 160.
12. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840 1847.
13. Das, I., Craig, C., Funahashi, Y., Jung, K.M., Kim, T.W., Byers, R., Weng, A.P., Kutok, J.L., Aster, J.C. Kitajewski, J. (2004) Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. Journal of Biological Chemistry, 279, 30771 30780.
14. Davies, S.P., Reddy, H., Caivano, M. Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemical Journal, 351, 95 105.
15. Deb, D.K., Sassano, A., Lekmine, F., Majchrzak, B., Verma, A., Kambhampati, S., Uddin, S., Rahman, A., Fish, E.N. Platanias, L.C. (2003) Activation of protein kinase C delta by IFN-gamma. Journal of Immunology, 171, 267 273.
16. Delespesse, G., Suter, U., Mossalayi, D., Bettler, B., Sarfati, M., Hofstetter, H., Kilcherr, E., Debre, P. Dalloul, A. (1991) Expression, structure, and function of the CD23 antigen. Advances in Immunology, 49, 149 191.
17. Dono, M., Cerruti, G. Zupo, S. (2004) The CD5+ B-cell. International Journal of Biochemistry & Cell Biology, 36, 2105 2111.
18. Duechler, M., Shehata, M., Schwarzmeier, J.D., Hoelbl, A., Hilgarth, M. Hubmann, R. (2005) Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. Leukemia, 19, 260 267.
19. Espinosa, L., Ingles-Esteve, J., Aguilera, C. Bigas, A. (2003) Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. Journal of Biological Chemistry, 278, 32227 32235.
20. Fournier, S., Delespesse, G., Rubio, M., Biron, G. Sarfati, M. (1992) CD23 antigen regulation and signaling in chronic lymphocytic leukemia. Journal of Clinical Investigation, 89, 1312 1321.
21. Fournier, S., Yang, L.P., Delespesse, G., Rubio, M., Biron, G. Sarfati, M. (1995) The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. British Journal of Haematololgy, 89, 373 379.
22. Goller, M.E., Kneitz, C., Mehringer, C., Muller, K., Jelley-Gibbs, D.M., Gosselin, E.J., Wilhelm, M. Tony, H.P. (2002) Regulation of CD23 isoforms on B-chronic lymphocytic leukemia. Leukemia Research, 26, 795 802.
23. Gschwendt, M., Muller, H.J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G. Marks, F. (1994) Rottlerin, a Novel Protein Kinase Inhibitor. Biochemical and Biophysical Research Communication, 199, 93 98.
24. Hayakawa, K. Hardy, R.R. (2000) Development and function of B-1 cells. Current Opinion in Immunology, 12, 346 353.
25. Herve, M., Xu, K., Ng, Y.S., Wardemann, H., Albesiano, E., Messmer, B.T., Chiorazzi, N. Meffre, E. (2005) Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. Journal of Clinical Investigation, 115, 1636 1643.
26. Hubmann, R., Schwarzmeier, J.D., Shehata, M., Hilgarth, M., Duechler, M., Dettke, M. Berger, R. (2002) Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia. Blood, 99, 3742 3747.
27. Kikutani, H., Suemura, M., Owaki, H., Nakamura, H., Sato, R., Yamasaki, K., Barsumian, E.L., Hardy, R.R. Kishimoto, T. (1986) Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. Journal of Experimental Medicine, 164, 1455 1469.
28. Kipps, T.J. (2000) Chronic lymphocytic leukemia. Current Opinion in Hematology, 7, 223 234.
29. Leong, K.G. Karsan, A. (2006) Recent insights into the role of Notch signaling in tumorigenesis. Blood, 107, 2223 2233.
30. McKenzie, G., Ward, G., Stallwood, Y., Briend, E., Papadia, S., Lennard, A., Turner, M., Champion, B. Hardingham, G.E. (2006) Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals. BMC Cell Biology, 7, 10.
31. Mecklenbrauker, I., Saijo, K., Zheng, N.Y., Leitges, M. Tarakhovsky, A. (2002) Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature, 416, 860 865.
32. Meinhardt, G., Wendtner, C.M. Hallek, M. (1999) Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. Journal of Molecular Medicine, 77, 282 293.
33. Melchers, F. (2006) Anergic B cells caught in the act. Immunity, 25, 864 867.
34. Micchelli, C.A., Esler, W.P., Kimberly, W.T., Jack, C., Berezovska, O., Kornilova, A., Hyman, B.T., Perrimon, N. Wolfe, M.S. (2003) Gamma-secretase/ presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila. FASEB Journal, 17, 79 81.
35. Miyamoto, A., Nakayama, K., Imaki, H., Hirose, S., Jiang, Y., Abe, M., Tsukiyama, T., Nagahama, H., Ohno, S., Hatakeyama, S. Nakayama, K.I. (2002) Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature, 416, 865 869.
36. Olson, R.E. Albright, C.F. (2008) Recent progress in the medicinal chemistry of gamma-secretase inhibitors. Current Topics in Medicinal Chemistry, 8, 17 33.
37. Pathan, N.I., Chu, P., Hariharan, K., Cheney, C., Molina, A. Byrd, J. (2008) Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines. Blood, 111, 1594 1602.
38. Rathmell, J.C. Thompson, C.B. (2002) Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell, 109, S97 S107.
39. Ringshausen, I., Schneller, F., Bogner, C., Hipp, S., Duyster, J., Peschel, C. Decker, T. (2002) Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta. Blood, 100, 3741 3748.
40. Ringshausen, I., Oelsner, M., Weick, K., Bogner, C., Peschel, C. Decker, T. (2006) Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL. Leukemia, 20, 514 520.
41. Rizzo, P., Osipo, C., Foreman, K., Golde, T., Osborne, B. Miele, L. (2008) Rational targeting of Notch signaling in cancer. Oncogene, 27, 5124 5131.
42. Rosati, E., Sabatini, R., Rampino, G., Tabilio, A., Di Ianni, M., Fettucciari, K., Bartoli, A., Coaccioli, S., Screpanti, I. Marconi, P. (2009) Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood, 113, 856 865.
43. Sarfati, M., Fournier, S., Christoffersen, M. Biron, G. (1990) Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leukemia Research, 14, 47 55.
44. Schwarzmeier, J., Hubmann, R., Duchler, M., Jager, U. Shehata, M. (2005) Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia. Leukemia and Lymphoma, 46, 157 165. (Pubitemid 40185944)
45. Serova, M., Ghoul, A., Benhadji, K.A., Cvitkovic, E., Faivre, S., Calvo, F., Lokiec, F. Raymond, E. (2006) Preclinical and clinical development of novel agents that target the protein kinase C family. Seminars in Oncology, 33, 466 478.
46. Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P., Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T. Aster, J.C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269 271.
47. Witt, C.M., Hurez, V., Swindle, C.S., Hamada, Y. Klug, C.A. (2003a) Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells. Molecular and Cellular Biology, 23, 8637 8650.
48. Witt, C.M., Won, W.J., Hurez, V. Klug, C.A. (2003b) Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. Journal of Immunology, 171, 2783 2788.